Data / Form D filings / Mitotherapeutix, LLC
Mitotherapeutix, LLC: Form D filings
Mitotherapeutix, LLC, a biotechnology company in Woodbridge, CT, filed 4 Form D notices with the SEC between 2016 and 2025. The latest, on May 22, 2025, reports $3 million sold of a $3 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4 Research Drive, Woodbridge, CT, 06525
- Phone
- (203) 498-4411
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1657701
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 22, 2025 | Amendment | $2,967,643 | $2,967,643 | 5 | Dec 12, 2017 | sec.gov | |
| Feb 5, 2020 | Amendment | $1,942,643 | $1,942,643 | 5 | Dec 12, 2017 | sec.gov | |
| Dec 28, 2017 | New notice | $1,000,000 | $942,643 | $57,357 | 4 | Dec 12, 2017 | sec.gov |
| Oct 3, 2016 | New notice | $30,000 | $30,000 | 1 | Sep 14, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fenel V. Eloi | Director | |
| Robert Hemley | Executive Officer, Director | |
| Robert Hennessey | Executive Officer, Director | |
| John V. Talley | Executive Officer, Director | |
| Daniel V. Wagner | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of May 19, 2025 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mitotherapeutix, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.